Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2

  1. Pritchard, K.I.
  2. Burris III, H.A.
  3. Ito, Y.
  4. Rugo, H.S.
  5. Dakhil, S.
  6. Hortobagyi, G.N.
  7. Campone, M.
  8. Csöszi, T.
  9. Baselga, J.
  10. Puttawibul, P.
  11. Piccart, M.
  12. Heng, D.
  13. Noguchi, S.
  14. Srimuninnimit, V.
  15. Bourgeois, H.
  16. Gonzalez Martin, A.
  17. Osborne, K.
  18. Panneerselvam, A.
  19. Taran, T.
  20. Sahmoud, T.
  21. Gnant, M.
Aldizkaria:
Clinical Breast Cancer

ISSN: 1938-0666,  1526-8209

Argitalpen urtea: 2013

Alea: 13

Zenbakia: 6

Orrialdeak: 421-432.e8

Mota: Artikulua

DOI: 10.1016/J.CLBC.2013.08.011 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus